Determination of gene copy number status in tert and terc among chronic myeloid leukaemia patients resist ant and responsive to imatinib mesylate treatment

The frontline treatment of chronic phase (CP) chronic myeloid leukaemia (CML) patients is the use of Imatinib Mesylate (IM). A remarkable CP CML (1/3) patients failed to achieve any degree of good response towards IM treatment. Cancer cells express a higher telomerase activity compared to normal cel...

Full description

Bibliographic Details

Main Author:	Asrari, Zaidatul Shakila Mohamad
Format:	Thesis
Language:	English
Published:	2014
Subjects:	R735-854 Medical education. Medical schools. Research RB Pathology RC Internal medicine
Online Access:	http://eprints.usm.my/62588/